Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 20, 2023
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
[ Tue, Jun 20th 2023
] - WOPRAI
Elemer Piros Reiterated (ATAI) at Strong Buy and Held Target at $15 on, Jun 20th, 2023
Elemer Piros of EF Hutton, Reiterated "Atai Life Sciences N.V." (ATAI) at Strong Buy and Held Target at $15 on, Jun 20th, 2023.
Elemer has made no other calls on ATAI in the last 4 months.
There are 2 other peers that have a rating on ATAI. Out of the 2 peers that are also analyzing ATAI, 0 agree with Elemer's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Elemer
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $20 on, Monday, May 15th, 2023
- Judah Frommer of "Credit Suisse" Reiterated at Buy and Held Target at $9 on, Friday, May 12th, 2023
